Another step forward for the Woman's Condom

Shanghai Food and Drug Administration grants approval

On May 27, 2011, the Woman’s Condom received Shanghai Food and Drug Administration (SHFDA) approval. PATH's licensee and the manufacturer of the product, the Shanghai Dahua Medical Apparatus Company (Dahua), submitted the application. SHFDA approval allows Dahua to register the Woman’s Condom for sale in the Chinese market. China is a significant market since one in five individuals in the world reside there. Dahua is planning for a product launch later this year with an initial focus on private-sector markets in large cities such as Shanghai.

In addition, the Protection Options for Women Product Development Partnership is working to create awareness and demand for the Woman’s Condom in the public sector in China with the end goal of including the Woman’s Condom in the national family planning program. This latest approval from the SHFDA, combined with CE Mark approval for sales in Europe (granted in December 2010), continues to build confidence about the quality of the Woman’s Condom product among donors, distributors, and end users.

For more information regarding the Woman’s Condom product, please contact:
Patricia Coffey, Woman’s Condom Project Director
PATH
PO Box 900922, Seattle, WA 98109, USA
womanscondom@path.org

For commercial inquiries, please contact:
Hua Chen, President
Shanghai Dahua Medical Apparatus Co., Ltd.
A-B Floor 20, Building 5, Lane 413, Lujiabang Road, Shanghai, China
shdahua1@msn.cn

Photos, from top: PATH, PATH/Glenn Austin.